Press Releases

MEMPHIS, Tenn., Oct. 15, 2019 /PRNewswire/ -- The world of music streaming now has a new voice: St. Jude Children's Research Hospital®. As an official Ap

Read more...

PHILADELPHIA, Oct. 15, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "the Company") today announced that the Nasdaq Hearings Panel has agreed to the transfer of the Company's shares to the Nasdaq Capital Market effective at the open of business on October 15, 2019 and granted the Company until Februar

Read more...

NEW YORK, Oct. 15, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that Robb Knie, Chief Exe

Read more...

PHILADELPHIA, Oct. 15, 2019 /PRNewswire/ -- TMRW, the creator of the first automated robotic cryo-specimen management system designed specifically for in vitro fertilization (IVF), today presented its initial validation study for automated cryo-storage and inventory management of patient specimens at the American Society for Reproductive Medicine's Scientific Congress an

Read more...

WEST LAFAYETTE, Ind., Oct. 15, 2019 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted imaging agents to improve cancer surgery, today announced that its lead molecule, OTL38, was shown to be safe and efficacious in a Phase 2 study. In this study surgeons were able to detect additional lesions in 48.3% o

Read more...

CRANFORD, N.J., Oct. 15, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the MicroCap Rodeo on Oct 16th at 9:45-10:15

Read more...

CAMBRIDGE, Mass., Oct. 15, 2019 /PRNewswire/ -- Vigeo Therapeutics, a clinical-stage biopharmaceutical company developing novel therapeutics to reprogram the tumor immune microenviro

Read more...

SANTA BARBARA, California, Oct. 15, 2019 /PRNewswire/ -- Yardi® Claims Manager is the newest addition to the Yardi® Senior Living Suite. It helps staff at senior living communities better manage reimbursements for care provided to Medicaid recipients.

Read more...

KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigational Device Exemption (IDE) clinical study by Dr. Jason M. Scopp

Read more...

SILICON VALLEY, Calif., Oct. 15, 2019 /PRNewswire/ -- Today, the beauty and wellness company Musely launches Face-Rx, a personalized prescription anti-aging skincare platform. Created by Musely Founder and CEO Jack Jia, Face-Rx provides users access to the best skincare medication to treat fine lines and wrinkles, sunspots and Melasma prescribed by Board Certified D

Read more...